Form 4 Regulus Therapeutics For: Aug 27 Filed by: ALNYLAM PHARMACEUTICALS, INC.
Tweet
Share
E-mail
http://archive.fast-edgar.com/20140829/ANZZJ22C3Z22K2CL22J82CZ2P63RZ22RZ562
Filed on: August 29, 2014
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MYTILINEOS ENERGY & METALS: FIRST QUARTER 2024 TRADING UPDATE
- Strategic Review Announcement
- ASE Technology Holding Co., Ltd. Reports Its Unaudited Consolidated Financial Results for the First Quarter of 2024
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
